# Open-Label Safety, Tolerability, PK Study of IV CXA-10 Emulsion in Subjects in Chronic Kidney Injury

> **NCT02248051** · PHASE1 · COMPLETED · sponsor: **Complexa, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Acute Kidney Injury (Nontraumatic)

## Interventions

- **DRUG:** CXA-10

## Key facts

- **NCT ID:** NCT02248051
- **Lead sponsor:** Complexa, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-08
- **Final completion:** 2015-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02248051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02248051, "Open-Label Safety, Tolerability, PK Study of IV CXA-10 Emulsion in Subjects in Chronic Kidney Injury". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02248051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*